Millions of vaccines donated to African countries by Canada and Britain will expire within a few weeks, triggering a rush to administer them before they are wasted, an African Union health expert says.
The urge to prevent losses in the soon-expiring donations is testimony to the global vaccine shortage, which has hit Africa more severely than any other region. Only about 3 per cent of Africans fully vaccinated so far.
Nigeria, Kenya and Niger are some of the countries to benefit from Canada’s program to donate 1.3 million doses to Africa.
Canada and Britain, which have fully vaccinated more than 60 per cent of their populations, are donating millions of AstraZeneca vaccines to Africa after deciding that they don’t need the doses that they had secured in earlier contracts.
But the British doses will expire at the end of this month and the Canadian doses will expire at the end of next month, according to Ayoade Alakija, co-chair of the African Union’s vaccine delivery alliance.
Canada has promised to donate 40 million vaccine doses to developing-world countries through the COVAX program. But based on publicly available information, only about 5 per cent of its promised amount has been delivered so far.
Canada’s biggest single donation, at this stage, is a batch of 801,600 AstraZeneca vaccines that arrived in Nigeria on Sept. 2.
In countries such as Nigeria, with huge populations and relatively poor infrastructure in some regions, it can take weeks to process and distribute the vaccines from their arrival point to vaccination sites on the ground, making it a tight race to use the vaccines before they expire.
Wealthy countries have promised to donate more than one billion vaccine doses, but less than 15 per cent of those doses have been delivered so far, according to the World Health Organization.
“There has been a lot of talk about vaccine equity, but too little action,” the WHO’s director-general, Tedros Adhanom Ghebreyesus, said in a media briefing on Wednesday.
“I will not stay silent when the companies and countries that control the global supply of vaccines think the world’s poor should be satisfied with leftovers.”
The shortage grew worse on Wednesday when officials announced a delay in shipments from the non-profit COVAX program, the main source of vaccines for low-income countries. Supplies this year will be about 25 per cent less than previously forecast, they said.
An analysis this week by Airfinity, a science information company, found that the world’s wealthy countries already have 500 million surplus vaccines that they could redistribute this month, and potentially 1.2 billon by the end of this year. The vast majority of these doses have not been earmarked for donations, it said.
UN Secretary General Dr Tedros urged the G20 group of countries, which includes Canada, to fulfill all of their donation pledges by the end of this month. He also urged all countries to refrain from giving booster shots to their people for the rest of this year, so that low-income countries have a better chance to vaccinate their most vulnerable. Canada is among those that have ordered millions of doses for booster shots.
Under targets set by the WHO, each of the world’s countries should vaccinate at least 10 per cent of their populations by the end of this month and 40 per cent by the end of this year. While most wealthy countries have reached these targets, not a single low-income country has done so, Dr. Tedros said.
Jason Nickerson, humanitarian representative to Canada for Médecins sans frontières (Doctors Without Borders), noted that Canada is expected to receive a further 95 million Pfizer and Moderna vaccine doses by the end of this month, even though it had already received enough doses to fully vaccinate every Canadian more than a month ago. The surplus doses should immediately be shared with people who have yet to receive a single dose, he said.
He also expressed concern about the reports of early expiry dates in the donated doses. “Less wealthy countries should not be dumping grounds for doses on the cusp of expiry,” he said.
The COVAX program, meanwhile, revealed that its vaccine deliveries this year will be 25 per cent less than forecast, mostly because of a continuing export ban in India, a disruption in manufacturing by AstraZeneca and Johnson & Johnson, and a delay in approvals for other vaccines.
